CTE: Well they do "cryogenics" which in my language is the study of objects at sub zero temperatures in this case blood. Also it's not easy for others to just compete with them because they have all that intellectual property etc. They store blood and cells for cancer and other research. eps up 210% cash flow good DTE 0.8 Revenues up 20% EBIT/EV=6% currently. Being in this area they usually demand higher multiples plus it looks like they can keep the top line and bottom line growth up in my opinion. ROC is 18%. Has potential in this sector I think.
anyone out there?, page-3
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CTE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
88.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $42.95M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | 92.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.32 | 12037 | 1 |
View Market Depth
| Last trade - 16.12pm 18/10/2024 (20 minute delay) ? |
| CTE (ASX) Chart |
Day chart unavailable